Background: Lung allograft rejection involves the interplay of multiple cel
lular populations, soluble mediators, and extracellular matrix proteins. Th
e CD44 family of cell surface glycoproteins mediates a variety of cell-cell
and cell-matrix interactions including lymphocyte homing to sites of antig
enic challenge and fibroblast migration and invasion into extracellular mat
rix, processes integral to lung allograft rejection.
Methods: We performed immunohistochemical staining for CD44 on biopsies fro
m allograft recipients with differing rejection experiences: Group 1 (n = 5
patients/10 biopsies) never exceeded Grade A1 or B2 acute rejection (AR);
Group 2 (n =7 patients/26 biopsies) had 2 or more episodes of Grade A2 or h
igher AR and no obliterative bronchiolitis (OB); Group 3 (n = 6 patients/17
biopsies) had clinical and pathologic OB. Nine infected allograft biopsies
, 8 near-normal lung sections (nontransplant controls), and 13 non-transpla
nt biopsies showing bronchiolitis obliterans organizing pneumonia (BOOP), o
rganizing diffuse alveolar damage (DAD),; or usual interstitial pneumonia (
UIP) were also studied.
Results: Allograft biopsies demonstrated significantly more CD44 staining a
mong; lymphocytes, macrophages, Type II pneumocytes, and respiratory epithe
lial cells than non-transplant controls, while staining of lymphocytes, mac
rophages, and Type II pneumocytes did not differ significantly between: all
ograft groups. Fibroblast CD44 staining in Group 3 biopsies significantly e
xceeded that of controls and Groups 1 and 2, and biopsies with AR and/or OB
showed more fibroblast staining than biopsies with BOOP, organizing DAD, o
r UIP. Alveolar CD44-positive fibroblasts did not predict development of OB
, while bronchial CD44-positive fibroblasts were followed in one case by OB
.
Conclusions: These findings suggest that CD44 expression is characteristic
of graft-infiltrating inflammatory cells and resident; parenchymal cells, a
nd may be related to the initiation and evolution of AR and OB.